Gene editing

New CRISPR-free gene-editing tool exploits bacterial warfare

New tool uses an interbacterial toxin to achieve precise mitochondrial gene editing without CRISPR side-effects. Mitochondria – often called the "powerhouse" of the cell –...

eGenesis’ xenotransplantation trials move closer to in-human

eGenesis' groundbreaking xenotransplantation work with Massachusetts General Hospital to be expanded through additional collaboration. eGenesis has announced it is expanding its research collaboration with the...

Wyss Institute and Cytosurge collaborate on CRISPR tech

The Wyss Institute at Harvard is joining forces with Swiss Biotech Cytosurge in a bid to improve CRISPR-based multiplexed gene editing with a single-cell...

Longevity2020: Day 5 Recap

On Friday, the Longevity2020 online conference drew to a close, and the final day explored what people can be doing today to address their...

Longevity2020: Day 2 recap

Yesterday at Longevity2020 was all about rejuvenation therapies, bringing together some of the world’s leading luminaries in the fight against aging. Things kicked off with...

BioViva to spin out its R&D and bioinformatics

CEO in the front-line: Liz Parrish talks gene therapy, patient data and funding. From academics and entrepreneurs to engineers and technologists, the battle against aging...

Reprogram, rejuvenate, rewind: spinout

Soaking up Longevity - a Stanford University team has rejuvenated aging human cells with a novel protein "bath" and formed a spinout. Researchers at Stanford...

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” - seeking investment to evolve world’s smallest syringe...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

Human CRISPR trial heralds Longevity success

Trial finds not only that gene-edited immune cells are safe, but that they survive and thrive after being placed into patients suffering from advanced...

Rejuvenate Bio teaches old dogs new tricks

A combination gene therapy developed by the Wyss Institute and Harvard Medical School is set to treat several age-related conditions in dogs, extending their...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

UK Gov releases human germline editing brief

Human Germline Genome Engineering is a highly controversial area – altering genes so that changes are passed on to all descendants.  Just because we...

Ageotype: Four new types of biomarker

You’ve obviously heard of stereotype. But how about an ageotype? Scientists have identified at least four types of aging, which could explain why we...

Healios bets on natural born killers

Healios is turning to natural killer cells (NK) to develop a range of new treatments which target solid tumours. Regenerative medicine innovator Healios KK has...

CRISPR in-body gene revolution gets underway

It has been an ethical minefield, but a scientific revolution. Could CRISPR in-body now be the next step in health span and lifespan therapies? Crispr...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

Primetime for more powerful CRISPR tech

Researchers have developed a novel and more powerful form of CRISPR that offers the possibility to correct most disease-causing genetic variations in DNA  –...

Machine learning and fast track gene therapy

Following latest research at Harvard's Wyss Institute, a machine learning tool could be key to the future of gene therapy delivery. Gene therapies have long...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Latest articles

Peptide molecule causes cancer cells to self destruct

New breakthrough by a team led by eminent oncologist Loren Walensky brings new hope for future cancer treatments – and Longevity.  Everyone needs a way...

WHO portal brings aging data together

We live in a world driven by data and the World Health Organization (WHO) has now launched the first data portal to bring together...

The natural medicine war chest to fight aging

Quicksilver's liposomal delivery system boasts a non-invasion of the body patchers. Colorado-based Quicksilver Scientific manufactures a range of supplements from immunity boosters to NAD+. By...

Jim Mellon and Phil Newman: Longevity interviews

Master Investor is a publication that helps private investors to take charge of their financial destiny: covering a range of subjects, from shares to...